Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OBINUTUZUMAB Cause Myocardial infarction? 73 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Myocardial infarction have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.5% of all adverse event reports for OBINUTUZUMAB.

73
Reports of Myocardial infarction with OBINUTUZUMAB
0.5%
of all OBINUTUZUMAB reports
22
Deaths
38
Hospitalizations

How Dangerous Is Myocardial infarction From OBINUTUZUMAB?

Of the 73 reports, 22 (30.1%) resulted in death, 38 (52.1%) required hospitalization, and 14 (19.2%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 73 reports have been filed with the FAERS database.

What Other Side Effects Does OBINUTUZUMAB Cause?

Off label use (1,584) Neutropenia (1,276) Febrile neutropenia (955) Covid-19 (942) Pyrexia (920) Thrombocytopenia (889) Disease progression (831) Infusion related reaction (789) Pneumonia (662) Anaemia (640)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which OBINUTUZUMAB Alternatives Have Lower Myocardial infarction Risk?

OBINUTUZUMAB vs OCELLA OBINUTUZUMAB vs OCRELIZUMAB OBINUTUZUMAB vs OCRIPLASMIN OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE

Related Pages

OBINUTUZUMAB Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction OBINUTUZUMAB Demographics